Экстренная контрацепция с помощью левоноргестрела – хорошо известный практикующим акушерам-гинекологам метод. Современная наука проанализировала безопасность его использования, за последнее время несколько изменила понимание механизма действия метода, дала ответ на вопрос о связи массы тела пациентки с его эффективностью.
Ключевые слова: экстренная контрацепция, левоноргестрел, безопасность, побочные эффекты, масса тела.
________________________________________________
Emergency contraception with levonorgestrel for the practicing obstetricians-ginecologist is a well-known method of contraception. The modern science has analyzed the safety issues of its use, and recently has changed the understanding of the method mechanism of action, and also gave the answer to the particular question about the relationship of the patient` weight with the effectiveness of the levonorgestrel Emergency Contraception method. Key words: emergency contraception, levonorgestrel, safety, side effects, weight.
1. Jackson RA, Schwarz EB, Freedman L et al. Advance supply of emergency contraception: effect on use and usual contraception: a randomized trial. Obstet Gynecol 2003; 102: 8–16.
2. Sanfilippo SJ. Emergency contraception, the bottom line. J Pediatr Adolesc Gynecol 2011; 24 (1): 1.
3. Dixon GW, Schlesselman JJ, Ory HW, Blye RP. Ethinyl estradiol and conjugated estrogens as postcoital contraceptives. J Am Med Assoc 1980; 244: 1336–9.
4. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 1995; 333: 1517–21.
5. Rodrigues I, Grou F, Joly J. Effectiveness of emergency contraception pills between 72 and 120 hours after unprotected sexual intercourse. Am J Obstet Gynecol 2001; 184: 531–7.
6. Raymond E, Taylor D, Trussell J, Steiner MJ. Minimum effectiveness of the levonorgestrel regimen of emergency contraception. Contraception 2004; 69: 79–81.
7. Croxatto et al. Mechanism of Action of Hormonal Preparations Used for Emergency Contraception: A Review of the Literature. Contraception 2001; 63: 111–2.
8. Прилепская В.Н., Бебнева Т.Н. Экстренная контрацепция с применением гестагенов. Гедеон Рихтер в СНГ. 2002; 3: 30–3.
9. Emergency contraception Fact sheet N244 July 2012 http://www.who. int/mediacentre/factsheets/fs244/ru/
10. Ерофеева Л.В. Профилактика незапланированной беременности у молодежи. Акуш. и гинекол. 2014; 5: 68–73.
11. Прилепская В.Н., Куземин А.А., Абакарова П.Р. Экстренная контрацепция. Гинекология. 2007; 3: 21–4.
12. Таенкова И.О., Таенкова А.А. Опыт использования срочной гормональной контрацепции в работе социального «кризисного» центра для молодежи. Дальневосточный мед. журн. 2000; 3: 78–9.
13. A national protocol for sexual assault medical forensic examinations, Second Edition. Washington DC: Department of Justice, 2013.
14. Goldenring JM, Allred G. Post-rape care in hospital emergency rooms. Am J Public Health 2001; 91: 1169–70.
15. Stewart FH, Trussell J. Prevention of pregnancy resulting from rape: A neglected preventive health measure. Am J Prev Med 2000; 19: 228–9.
16. International Federation of Gynecology & Obstetrics (FIGO), International Consortuim on Emergency Contraception (ICEC). Mechanism of Action: How do levonorgestrel-only emergency contraceptive pills (LNG ECPs) prevent pregnancy? www.cecinfo.org.
17. Meyer JL, Gold MA. Haggerty Advance provision of emergency contraception among adolescent and young adult women: a systematic review of literature. J Pediatr Adolesc Gynecol 2011; 24: 2–9.
18. Gold MA, Wolford JE, Smith KA et al. The effects of advance provision of emergency contraception on adolescent women's sexual and contraceptive behaviors. J Pediatr Adolesc Gynecol 2004; 17: 87–96.
19. Statement on Contraceptive Methods. Washington DC: American College of Obstetricians and Gynecologists, July 1998.
20. Díaz S, Cárdenas H, Brandeis A et al. Relative contributions of anovulation and luteal phase defect to the reduced pregnancy rate of breastfeeding women. Fertil Steril 1992; 58: 498–503.
21. Lewis PR, Brown JB, Renfree MB, Short RV. The resumption of ovulation and menstruation in a well-nourished population of women breastfeeding for an extended period of time. Fertil Steril 1991; 55: 529–36.
22. Brown JB, Harrisson P, Smith MA. A study of returning fertility after childbirth and during lactation by measurement of urinary oestrogen and pregnanediol excretion and cervical mucus production. J Biosoc Sci 1985; 9 (Suppl.): 5–23.
23. Gray RH, Campbell OM, Apelo R et al. Risk of ovulation during lactation. Lancet 1990; 335: 25–9.
24. Swahn ML, Westlund P, Johannisson E, Bygdeman M. Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle. Acta Obstet Gynecol Scand 1996; 75: 738–44.
25. Ling WY, Robichaud A, Zayid I et al. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. Fertil Steril 1979; 32: 297–302.
26. Rowlands S, Kubba AA, Guillebaud J, Bounds W. A possible mechanism of action of danazol and an ethinylestradiol/norgestrel combination used as postcoital contraceptive agents. Contraception 1986; 33: 539–45.
27. Croxatto HB, Fuentalba B, Brache V et al. Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function. Contraception 2002; 65: 121–8.
28. Kubba AA, White JO, Guillebaud J, Elder MG. The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinylestradiol combination or danazol. Fertil Steril 1986; 45: 512–6.
29. Ling WY, Wrixon W, Zayid I et al. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium. Fertil Steril 1983; 39: 292–7.
30. Yuzpe AA, Thurlow HJ, Ramzy I, Leyshon JI. Post coital contraception – a pilot study. J Reprod Med 1974; 13: 53–8.
31. Taskin O, Brown RW, Young DC et al. High doses of oral contraceptives do not alter endometrial α1 and ανβ3integrins in the late implantation window. Fertil Steril 1994; 61: 850–5.
32. Raymond EG, Lovely LP, Chen-Mok M et al. Effect of the Yuzpe regimen of emergency contraception on markers of endometrial receptivity. Hum Reprod 2000; 15: 2351–5.
33. Ling WY, Wrixon W, Acorn T et al. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis. Fertil Steril 1983; 40: 631–6.
34. Croxatto HB, Devoto L, Durand M et al. Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraception 2001; 63: 111–21.
35. Croxatto HB, Ortiz ME, Müller AL. Mechanisms of action of emergency contraception. Steroids 2003; 68: 1095–8.
36. Durand M, del Carmen Cravioto M, Raymond EG et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception 2001; 64: 227–34.
37. Marions L, Hultenby K, Lindell I et al. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol 2002; 100: 65–71.
38. Marions L, Cekan SZ, Bygdeman M, Gemzell-Danielsson K. Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function. Contraception 2004; 69: 373–7.
39. Okewole IA, Arowojolu AO, Odusoga OL et al. Effect of single administration of levonorgestrel on the menstrual cycle. Contraception 2007; 75: 372–7.
40. Durand M, del Carmen Cravioto M, Raymond EG et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception 2001; 64: 227–34.
41. Palomino WA, Kohen P, Devoto L. A single midcycle dose of levonorgestrel similar to emergency contraceptive does not alter the expression of the L-selectin ligand or molecular markers of endometrial receptivity. Fertil Steril 2010; 94: 1589–94.
42. Lalitkumar PG, Lalitkumar S, Meng CX et al. Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model. Human Reprod 2007; 22: 3031–7.
43. Meng CX, Andersson KL, Bentin-Ley U et al. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model. Fertil Steril 2009; 91: 256–64.
44. Kesserü E, Garmendia F, Westphal N, Parada J. The hormonal and peripheral effects of d-norgestrel in postcoital contraception. Contraception 1974; 10: 411–24.
45. Do Nascimento JA, Seppala M, Perdigao A et al. In vivo assessment of the human sperm acrosome reaction and the expression of glycodelin-A in human endometrium after levonorgestrel-emergency contraceptive pill administration. Hum Reprod 2007; 22: 2190–5.
46. Yeung WS, Chiu PC, Wang CH et al. The effects of levonorgestrel on various sperm functions. Contraception 2002; 66: 453–7.
47. Медицинские критерии приемлемости контрацепции в РФ. М., 2012.
48. Task Force on Post-Ovulatory Methods of Fertility Regulation. Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. Contraception 2000; 61: 303–8.
49. Ho PC, Kwan MS. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod 1993; 8: 389–92.
50. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998; 352: 428–33.
51. Dada OA, Godfrey EM, Gilda Piaggio G, von Hertzen H. A randomized, double-blind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria. Contraception 2010; 82: 373–8.
52. Farajkhoda T, Khoshbin A, Enjezab B et al. Assessment of two emergency contraceptive regimens in Iran: levonorgestrel ver Raymond EG, Goldberg A, Trussell J, Hays M, Roach E, Taylor D. Bleeding patterns after use of levonorgestrel emergency contraceptive pills. Contraception 2006; 73: 376–81.
53. Erratum. Contraception 2006; 74: 349–50.
54. Gainer E, Kenfack B, Mboudou E et al. Menstrual bleeding patterns following levonorgestrel emergency contraception. Contraception 2006; 74: 118–24.
55. Tirelli A, Cagnacci A, Volpe A. Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function. Contraception 2008; 77: 328–32.
56. Glasier A. Emergency postcoital contraception. N Engl J Med 1997; 337: 1058–64.
57. Zhang L, Chen J, Wang Y et al. Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod 2009; 24: 1605–11.
58. Raman-Wilms L, Tseng AL, Wighardt S et al. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol 1995; 85: 141–9.
59. Bracken MB. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol 1990; 76: 552–7.
60. Simpson JL, Phillips OP. Spermicides, hormonal contraception and congenital malformations. Adv Contraception 1990; 6: 141–67.
61. Food and Drug Administration. Prescription drug products; certain combined oral contraceptives for use as postcoital emergency contraception. Federal Regist 1997; 62: 8610–2.
62. Trussell J, Hedley A, Raymond E. Ectopic pregnancy following use of progestin-only ECPs [letter]. J Fam Plann Reprod Health Care 2003; 29: 249.
63. Cleland K, Raymond E, Trussell J et al. Ectopic pregnancy and emergency contraception: a systematic review. Obstet Gynecol 2010; 115: 1263–6.
64. Brown JB, Harrisson P, Smith MA. A study of returning fertility after childbirth and during lactation by measurement of urinary oestrogen and pregnanediol excretion and cervical mucus production. J Biosoc Sci 1985; 9 (Suppl.): 5–23.
65. Gray RH, Campbell OM, Apelo R et al. Risk of ovulation during lactation. Lancet 1990; 335: 25–9.
66. Gainer E, Massai R, Lillo S et al. Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1,5 mg for emergency contraception. Hum Reprod 2007; 22: 1578–84.
67. Polakow-Farkash S, Gilad O, Merlob P et al. Levonorgestrel used for emergency contraception during lactation-A prospective observational cohort study on maternal and infant safety. J Matern Fetal Neonatal Med 2013; 26: 219–21.
68. Ellertson C, Trussell J, Stewart F, Winikoff B. Should emergency contraceptive pills be available without prescription? J Am Med Wom Assoc 1998; 53 (Suppl. 2): 226–9, 232.
69. Grimes DA, Raymond EG, Scott Jones B. Emergency contraception over-the-counter: the medical and legal imperatives. Obstet Gynecol 2001; 98: 151–5.
70. Association of Reproductive Health Professionals. ARHP sign-on letter: Switch status of emergency contraceptive from Rx to OTC. Available at http://arhp.org/uploadDocs/ec_signon.pdf. Accessed 15 June 2010.
71. Glasier A, Cameron ST, Blithe D et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011; 84: 363–7.
72. Prabakar I, Webb A. Emergency Contraception. BMJ 2012; 344: e1492.
73. Statement from Clinical Effectiveness Unit on Labelling of Levonorgestrel emergency contraception in Europe: reports of new advice on body weight and efficacy. Faculty of Reproductive and Sexual Healthcare. November 2013 http://www.fsrh.org/pdfs/CEUstatementLabellingLevonorgestrelEmergencyContraceptionEurope.pdf
74. Statement from Clinical Effectiveness Unit on Labelling of Levonorgestrel emergency contraception in Europe: reports of new advice on body weight and efficacy. Faculty of Reproductive and Sexual Healthcare. November 2013. http://www.fsrh.org/pdfs/CEUstatementLabellingLevonorgestrelEmergencyContraceptionEurope.pdf
75. European Medicines Agency Statement «Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight» from 24/07/2014 http://www.ema.europa.eu/ema/ index.jsp?curl=pages/news_and_events/news/2014/07/news_detail_002145.jsp&mid=WC0b01ac058004d5c1
________________________________________________
1. Jackson RA, Schwarz EB, Freedman L et al. Advance supply of emergency contraception: effect on use and usual contraception: a randomized trial. Obstet Gynecol 2003; 102: 8–16.
2. Sanfilippo SJ. Emergency contraception, the bottom line. J Pediatr Adolesc Gynecol 2011; 24 (1): 1.
3. Dixon GW, Schlesselman JJ, Ory HW, Blye RP. Ethinyl estradiol and conjugated estrogens as postcoital contraceptives. J Am Med Assoc 1980; 244: 1336–9.
4. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 1995; 333: 1517–21.
5. Rodrigues I, Grou F, Joly J. Effectiveness of emergency contraception pills between 72 and 120 hours after unprotected sexual intercourse. Am J Obstet Gynecol 2001; 184: 531–7.
6. Raymond E, Taylor D, Trussell J, Steiner MJ. Minimum effectiveness of the levonorgestrel regimen of emergency contraception. Contraception 2004; 69: 79–81.
7. Croxatto et al. Mechanism of Action of Hormonal Preparations Used for Emergency Contraception: A Review of the Literature. Contraception 2001; 63: 111–2.
8. Прилепская В.Н., Бебнева Т.Н. Экстренная контрацепция с применением гестагенов. Гедеон Рихтер в СНГ. 2002; 3: 30–3.
9. Emergency contraception Fact sheet N244 July 2012 http://www.who. int/mediacentre/factsheets/fs244/ru/
10. Ерофеева Л.В. Профилактика незапланированной беременности у молодежи. Акуш. и гинекол. 2014; 5: 68–73.
11. Прилепская В.Н., Куземин А.А., Абакарова П.Р. Экстренная контрацепция. Гинекология. 2007; 3: 21–4.
12. Таенкова И.О., Таенкова А.А. Опыт использования срочной гормональной контрацепции в работе социального «кризисного» центра для молодежи. Дальневосточный мед. журн. 2000; 3: 78–9.
13. A national protocol for sexual assault medical forensic examinations, Second Edition. Washington DC: Department of Justice, 2013.
14. Goldenring JM, Allred G. Post-rape care in hospital emergency rooms. Am J Public Health 2001; 91: 1169–70.
15. Stewart FH, Trussell J. Prevention of pregnancy resulting from rape: A neglected preventive health measure. Am J Prev Med 2000; 19: 228–9.
16. International Federation of Gynecology & Obstetrics (FIGO), International Consortuim on Emergency Contraception (ICEC). Mechanism of Action: How do levonorgestrel-only emergency contraceptive pills (LNG ECPs) prevent pregnancy? www.cecinfo.org.
17. Meyer JL, Gold MA. Haggerty Advance provision of emergency contraception among adolescent and young adult women: a systematic review of literature. J Pediatr Adolesc Gynecol 2011; 24: 2–9.
18. Gold MA, Wolford JE, Smith KA et al. The effects of advance provision of emergency contraception on adolescent women's sexual and contraceptive behaviors. J Pediatr Adolesc Gynecol 2004; 17: 87–96.
19. Statement on Contraceptive Methods. Washington DC: American College of Obstetricians and Gynecologists, July 1998.
20. Díaz S, Cárdenas H, Brandeis A et al. Relative contributions of anovulation and luteal phase defect to the reduced pregnancy rate of breastfeeding women. Fertil Steril 1992; 58: 498–503.
21. Lewis PR, Brown JB, Renfree MB, Short RV. The resumption of ovulation and menstruation in a well-nourished population of women breastfeeding for an extended period of time. Fertil Steril 1991; 55: 529–36.
22. Brown JB, Harrisson P, Smith MA. A study of returning fertility after childbirth and during lactation by measurement of urinary oestrogen and pregnanediol excretion and cervical mucus production. J Biosoc Sci 1985; 9 (Suppl.): 5–23.
23. Gray RH, Campbell OM, Apelo R et al. Risk of ovulation during lactation. Lancet 1990; 335: 25–9.
24. Swahn ML, Westlund P, Johannisson E, Bygdeman M. Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle. Acta Obstet Gynecol Scand 1996; 75: 738–44.
25. Ling WY, Robichaud A, Zayid I et al. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. Fertil Steril 1979; 32: 297–302.
26. Rowlands S, Kubba AA, Guillebaud J, Bounds W. A possible mechanism of action of danazol and an ethinylestradiol/norgestrel combination used as postcoital contraceptive agents. Contraception 1986; 33: 539–45.
27. Croxatto HB, Fuentalba B, Brache V et al. Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function. Contraception 2002; 65: 121–8.
28. Kubba AA, White JO, Guillebaud J, Elder MG. The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinylestradiol combination or danazol. Fertil Steril 1986; 45: 512–6.
29. Ling WY, Wrixon W, Zayid I et al. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium. Fertil Steril 1983; 39: 292–7.
30. Yuzpe AA, Thurlow HJ, Ramzy I, Leyshon JI. Post coital contraception – a pilot study. J Reprod Med 1974; 13: 53–8.
31. Taskin O, Brown RW, Young DC et al. High doses of oral contraceptives do not alter endometrial α1 and ανβ3integrins in the late implantation window. Fertil Steril 1994; 61: 850–5.
32. Raymond EG, Lovely LP, Chen-Mok M et al. Effect of the Yuzpe regimen of emergency contraception on markers of endometrial receptivity. Hum Reprod 2000; 15: 2351–5.
33. Ling WY, Wrixon W, Acorn T et al. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis. Fertil Steril 1983; 40: 631–6.
34. Croxatto HB, Devoto L, Durand M et al. Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraception 2001; 63: 111–21.
35. Croxatto HB, Ortiz ME, Müller AL. Mechanisms of action of emergency contraception. Steroids 2003; 68: 1095–8.
36. Durand M, del Carmen Cravioto M, Raymond EG et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception 2001; 64: 227–34.
37. Marions L, Hultenby K, Lindell I et al. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol 2002; 100: 65–71.
38. Marions L, Cekan SZ, Bygdeman M, Gemzell-Danielsson K. Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function. Contraception 2004; 69: 373–7.
39. Okewole IA, Arowojolu AO, Odusoga OL et al. Effect of single administration of levonorgestrel on the menstrual cycle. Contraception 2007; 75: 372–7.
40. Durand M, del Carmen Cravioto M, Raymond EG et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception 2001; 64: 227–34.
41. Palomino WA, Kohen P, Devoto L. A single midcycle dose of levonorgestrel similar to emergency contraceptive does not alter the expression of the L-selectin ligand or molecular markers of endometrial receptivity. Fertil Steril 2010; 94: 1589–94.
42. Lalitkumar PG, Lalitkumar S, Meng CX et al. Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model. Human Reprod 2007; 22: 3031–7.
43. Meng CX, Andersson KL, Bentin-Ley U et al. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model. Fertil Steril 2009; 91: 256–64.
44. Kesserü E, Garmendia F, Westphal N, Parada J. The hormonal and peripheral effects of d-norgestrel in postcoital contraception. Contraception 1974; 10: 411–24.
45. Do Nascimento JA, Seppala M, Perdigao A et al. In vivo assessment of the human sperm acrosome reaction and the expression of glycodelin-A in human endometrium after levonorgestrel-emergency contraceptive pill administration. Hum Reprod 2007; 22: 2190–5.
46. Yeung WS, Chiu PC, Wang CH et al. The effects of levonorgestrel on various sperm functions. Contraception 2002; 66: 453–7.
47. Медицинские критерии приемлемости контрацепции в РФ. М., 2012.
48. Task Force on Post-Ovulatory Methods of Fertility Regulation. Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. Contraception 2000; 61: 303–8.
49. Ho PC, Kwan MS. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod 1993; 8: 389–92.
50. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998; 352: 428–33.
51. Dada OA, Godfrey EM, Gilda Piaggio G, von Hertzen H. A randomized, double-blind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria. Contraception 2010; 82: 373–8.
52. Farajkhoda T, Khoshbin A, Enjezab B et al. Assessment of two emergency contraceptive regimens in Iran: levonorgestrel ver Raymond EG, Goldberg A, Trussell J, Hays M, Roach E, Taylor D. Bleeding patterns after use of levonorgestrel emergency contraceptive pills. Contraception 2006; 73: 376–81.
53. Erratum. Contraception 2006; 74: 349–50.
54. Gainer E, Kenfack B, Mboudou E et al. Menstrual bleeding patterns following levonorgestrel emergency contraception. Contraception 2006; 74: 118–24.
55. Tirelli A, Cagnacci A, Volpe A. Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function. Contraception 2008; 77: 328–32.
56. Glasier A. Emergency postcoital contraception. N Engl J Med 1997; 337: 1058–64.
57. Zhang L, Chen J, Wang Y et al. Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod 2009; 24: 1605–11.
58. Raman-Wilms L, Tseng AL, Wighardt S et al. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol 1995; 85: 141–9.
59. Bracken MB. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol 1990; 76: 552–7.
60. Simpson JL, Phillips OP. Spermicides, hormonal contraception and congenital malformations. Adv Contraception 1990; 6: 141–67.
61. Food and Drug Administration. Prescription drug products; certain combined oral contraceptives for use as postcoital emergency contraception. Federal Regist 1997; 62: 8610–2.
62. Trussell J, Hedley A, Raymond E. Ectopic pregnancy following use of progestin-only ECPs [letter]. J Fam Plann Reprod Health Care 2003; 29: 249.
63. Cleland K, Raymond E, Trussell J et al. Ectopic pregnancy and emergency contraception: a systematic review. Obstet Gynecol 2010; 115: 1263–6.
64. Brown JB, Harrisson P, Smith MA. A study of returning fertility after childbirth and during lactation by measurement of urinary oestrogen and pregnanediol excretion and cervical mucus production. J Biosoc Sci 1985; 9 (Suppl.): 5–23.
65. Gray RH, Campbell OM, Apelo R et al. Risk of ovulation during lactation. Lancet 1990; 335: 25–9.
66. Gainer E, Massai R, Lillo S et al. Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1,5 mg for emergency contraception. Hum Reprod 2007; 22: 1578–84.
67. Polakow-Farkash S, Gilad O, Merlob P et al. Levonorgestrel used for emergency contraception during lactation-A prospective observational cohort study on maternal and infant safety. J Matern Fetal Neonatal Med 2013; 26: 219–21.
68. Ellertson C, Trussell J, Stewart F, Winikoff B. Should emergency contraceptive pills be available without prescription? J Am Med Wom Assoc 1998; 53 (Suppl. 2): 226–9, 232.
69. Grimes DA, Raymond EG, Scott Jones B. Emergency contraception over-the-counter: the medical and legal imperatives. Obstet Gynecol 2001; 98: 151–5.
70. Association of Reproductive Health Professionals. ARHP sign-on letter: Switch status of emergency contraceptive from Rx to OTC. Available at http://arhp.org/uploadDocs/ec_signon.pdf. Accessed 15 June 2010.
71. Glasier A, Cameron ST, Blithe D et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011; 84: 363–7.
72. Prabakar I, Webb A. Emergency Contraception. BMJ 2012; 344: e1492.
73. Statement from Clinical Effectiveness Unit on Labelling of Levonorgestrel emergency contraception in Europe: reports of new advice on body weight and efficacy. Faculty of Reproductive and Sexual Healthcare. November 2013 http://www.fsrh.org/pdfs/CEUstatementLabellingLevonorgestrelEmergencyContraceptionEurope.pdf
74. Statement from Clinical Effectiveness Unit on Labelling of Levonorgestrel emergency contraception in Europe: reports of new advice on body weight and efficacy. Faculty of Reproductive and Sexual Healthcare. November 2013. http://www.fsrh.org/pdfs/CEUstatementLabellingLevonorgestrelEmergencyContraceptionEurope.pdf
75. European Medicines Agency Statement «Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight» from 24/07/2014 http://www.ema.europa.eu/ema/ index.jsp?curl=pages/news_and_events/news/2014/07/news_detail_002145.jsp&mid=WC0b01ac058004d5c1
Авторы
Л.В.Ерофеева1, В.Н.Прилепская2, 3
1. Общероссийская общественная организация содействия охране репродуктивного здоровья населения «Российская ассоциация «Народонаселение и Развитие»;
2. Российское общество по контрацепции;
3. ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава России, Москва;